Anticandidal Therapeutics

Dr. Awanish Kumar is currently an Associate Professor in the Department of Biotechnology at the National Institute of Technology, Raipur (CG), India. He has more than 13 years of research experience. He received his PhD in Molecular Parasitology from the CSIR-Central Drug Research Institute, Lucknow, India, and Jawaharlal Nehru University, Delhi, India, and completed his postdoctoral studies at McGill University, Montreal, Canada. His research interests are infection biology, drug targeting, and drug discovery. Dr. Kumar has served on various national and international organizations in different academic and research capacities. He has also served on many national committees and scientific advisory panels, as a member of many international professional research societies, and as a reviewer and editorial board member of reputed and refereed journals. He has authored or edited several monographs, books, and book chapters. Dr. Anubhuti Jha works in the area of antifungal drug discovery. She has obtained PhD degree from Department of Biotechnology, National Institute of Technology, Raipur (CG), India. She has published more than 15 research paper in peer_x0002_reviewed journals and has authored several books/chapters.

1. History of infection 2. Brief introduction on infection 3. Fungal diseases and antifungal drugs 4. Multidrug transporters of fungal pathogen Candida 5. Essential anticandidal targets 6. Stages of anticandidal agent development 7. Recent trends and progress in antifungal translational research 8. Clinical status of anticandidal therapeutic agents 9. Drug repurposing for development of effective anticandidals 10. Commercial aspects of drug development 11. Challenges and future prospects